Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 4
2011 3
2013 2
2014 1
2017 3
2018 1
2019 2
2020 3
2021 13
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling.
Gobbi G, Grieco A, Torricelli F, Sauta E, Santandrea G, Zanetti E, Fantini V, Reggiani F, Strocchi S, Paci M, Vohra M, Saladi SV, Ambrosetti DC, Ciarrocchi A, Sancisi V. Gobbi G, et al. Among authors: zanetti e. Cell Death Dis. 2023 Nov 18;14(11):752. doi: 10.1038/s41419-023-06277-y. Cell Death Dis. 2023. PMID: 37980331 Free PMC article.
Medullary Thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion.
Torricelli F, Santandrea G, Botti C, Ragazzi M, Vezzani S, Frasoldati A, Ghidini A, Giordano D, Zanetti E, Rossi T, Nicoli D, Ciarrocchi A, Piana S. Torricelli F, et al. Among authors: zanetti e. Mod Pathol. 2023 Sep;36(9):100244. doi: 10.1016/j.modpat.2023.100244. Epub 2023 Jun 10. Mod Pathol. 2023. PMID: 37307881
Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach.
Zanelli M, Palicelli A, Sanguedolce F, Zizzo M, Filosa A, Ricci L, Cresta C, Martino G, Bisagni A, Zanetti E, di Donato F, Melli B, Soriano A, Cimino L, Cavazza A, Vivian LF, Ascani S. Zanelli M, et al. Among authors: zanetti e. Curr Oncol. 2022 Apr 24;29(5):3026-3043. doi: 10.3390/curroncol29050246. Curr Oncol. 2022. PMID: 35621636 Free PMC article.
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes.
Palicelli A, Croci S, Bisagni A, Zanetti E, De Biase D, Melli B, Sanguedolce F, Ragazzi M, Zanelli M, Chaux A, Cañete-Portillo S, Bonasoni MP, Ascani S, De Leo A, Giordano G, Landriscina M, Carrieri G, Cormio L, Gandhi J, Nicoli D, Farnetti E, Piana S, Tafuni A, Bonacini M. Palicelli A, et al. Among authors: zanetti e. Biomedicines. 2022 Jan 22;10(2):236. doi: 10.3390/biomedicines10020236. Biomedicines. 2022. PMID: 35203446 Free PMC article. Review.
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid Biopsy.
Palicelli A, Bonacini M, Croci S, Bisagni A, Zanetti E, De Biase D, Sanguedolce F, Ragazzi M, Zanelli M, Chaux A, Cañete-Portillo S, Bonasoni MP, Ascani S, De Leo A, Gandhi J, Tafuni A, Melli B. Palicelli A, et al. Among authors: zanetti e. J Pers Med. 2021 Dec 6;11(12):1312. doi: 10.3390/jpm11121312. J Pers Med. 2021. PMID: 34945784 Free PMC article. Review.
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables.
Palicelli A, Bonacini M, Croci S, Magi-Galluzzi C, Cañete-Portillo S, Chaux A, Bisagni A, Zanetti E, De Biase D, Melli B, Sanguedolce F, Ragazzi M, Bonasoni MP, Soriano A, Ascani S, Zizzo M, Castro Ruiz C, De Leo A, Giordano G, Landriscina M, Carrieri G, Cormio L, Berney DM, Athanazio D, Gandhi J, Cavazza A, Santandrea G, Tafuni A, Zanelli M. Palicelli A, et al. Among authors: zanetti e. Cells. 2021 Nov 14;10(11):3166. doi: 10.3390/cells10113166. Cells. 2021. PMID: 34831389 Free PMC article.
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic-Pathologic Correlations.
Palicelli A, Bonacini M, Croci S, Magi-Galluzzi C, Cañete-Portillo S, Chaux A, Bisagni A, Zanetti E, De Biase D, Melli B, Sanguedolce F, Zanelli M, Bonasoni MP, De Marco L, Soriano A, Ascani S, Zizzo M, Castro Ruiz C, De Leo A, Giordano G, Landriscina M, Carrieri G, Cormio L, Berney DM, Gandhi J, Santandrea G, Gelli MC, Tafuni A, Ragazzi M. Palicelli A, et al. Among authors: zanetti e. Cells. 2021 Nov 14;10(11):3165. doi: 10.3390/cells10113165. Cells. 2021. PMID: 34831388 Free PMC article.
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment.
Palicelli A, Croci S, Bisagni A, Zanetti E, De Biase D, Melli B, Sanguedolce F, Ragazzi M, Zanelli M, Chaux A, Cañete-Portillo S, Bonasoni MP, Soriano A, Ascani S, Zizzo M, Castro Ruiz C, De Leo A, Giordano G, Landriscina M, Carrieri G, Cormio L, Berney DM, Gandhi J, Copelli V, Bernardelli G, Santandrea G, Bonacini M. Palicelli A, et al. Among authors: zanetti e. Int J Mol Sci. 2021 Nov 15;22(22):12330. doi: 10.3390/ijms222212330. Int J Mol Sci. 2021. PMID: 34830209 Free PMC article.
36 results